Róka R, Demaude J, Cenac N, Ferrier L, Salvador-Cartier C, Garcia-Villar R, Fioramonti J, Bueno L
INRA Neuro-Gastroenterology & Nutrition Unit, Toulouse, France.
Neurogastroenterol Motil. 2007 Jan;19(1):57-65. doi: 10.1111/j.1365-2982.2006.00851.x.
Luminal activation of protease-activated receptors-2 (PAR(2)) on colonocytes by trypsin or PAR(2)-activating peptide increases colonic paracellular permeability (CPP). The aim of this study was to evaluate the role of proteases from endogenous and bacterial origin in the modulation of CPP and colonocyte PAR(2) expression in mice. CPP was assessed with (51)Cr-EDTA after intracolonic administration of different protease inhibitors. After 12 days of oral antibiotic treatment, measurements of colonic luminal serine protease activity (CLSPA), CPP, mucosal mouse mast cell proteinase-1 (MMCP-1) content, immunochemistry of PAR(2) and assessment of effects of PAR(2) agonist (SLIGRL) and mast cell degranulator (C48/80) on CPP in Ussing chambers were performed. Immunochemistry was repeated after intracolonic trypsin administration. Colonic infusion of protease inhibitors significantly reduced CPP. In antibiotic-treated mice, CLSPA was reduced coupled with a decrease in PAR(2) expression, but with no change in CPP and MMCP-1 content. Trypsin administration restored PAR(2) expression. The increase in CPP induced by SLIGRL and C48/80 was reduced after antibiotic treatment. Protease activity of colonic content plays an important role in the regulation of mucosal barrier through activation of PAR(2).
胰蛋白酶或蛋白酶激活受体-2(PAR(2))激活肽对结肠细胞上PAR(2)的管腔激活会增加结肠旁细胞通透性(CPP)。本研究旨在评估内源性和细菌来源的蛋白酶在调节小鼠CPP和结肠细胞PAR(2)表达中的作用。在结肠内给予不同的蛋白酶抑制剂后,用(51)Cr-乙二胺四乙酸评估CPP。口服抗生素治疗12天后,进行结肠管腔丝氨酸蛋白酶活性(CLSPA)、CPP、黏膜小鼠肥大细胞蛋白酶-1(MMCP-1)含量的测量,PAR(2)的免疫化学检测以及在尤斯灌流小室中评估PAR(2)激动剂(SLIGRL)和肥大细胞脱颗粒剂(C48/80)对CPP的影响。结肠内注射胰蛋白酶后重复进行免疫化学检测。结肠灌注蛋白酶抑制剂可显著降低CPP。在抗生素治疗的小鼠中,CLSPA降低,同时PAR(2)表达减少,但CPP和MMCP-1含量无变化。给予胰蛋白酶可恢复PAR(2)表达。抗生素治疗后,SLIGRL和C48/80诱导的CPP增加有所减少。结肠内容物的蛋白酶活性通过激活PAR(2)在黏膜屏障调节中起重要作用。